Fabian Dingfelder is a Senior Scientist at Johnson & Johnson, specializing in biologics and protein biophysics. With a PhD in Molecular Biophysics from Universität Zürich, Fabian has conducted advanced research at institutions like Novo Nordisk and has collaborated with ETH Zurich on antibody stability assays. Their work emphasizes innovative methodologies and the integration of technology to propel developments in the biopharmaceutical industry. Fabian's passion for exploration and innovation drives their contributions to therapeutic development and analytical processes in clinical trials.
This person is not in the org chart
This person is not in any teams
This person is not in any offices